The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
97878963 9787896 3 F 20160725 20131230 20160802 EXP JP-JNJFOC-20131216288 JANSSEN HIGASHI Y, TADA K, YAMASUJI Y, SHIMOKAWA M, KANEKURA T. ELEVATION OF SERUM KL-6 IN PATIENTS WITH PSORIASIS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR- THERAPY. CLINICAL AND EXPERIMENTAL DERMATOLOGY 2016;41(1):88-90. HIGASHI Y, TADA K, YAMASUJI Y, SHIMOKAWA M, KANEKURA T. A CASE OF PSORIATIC ARTHRITIS WITH ELEVATED KL-6 LEVEL UNDER ANTI-TNF-ALPHA THERAPY. THE 28TH ANNUAL MEETING OF THE JAPANESE SOCIETY FOR PSORIASIS RESEARCH 2013:195. 50.00 YR A M Y 0.00000 20160802 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
97878963 9787896 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N UNKNOWN 0 5 MG/KG LYOPHILIZED POWDER
97878963 9787896 2 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N UNKNOWN 103772 5 MG/KG LYOPHILIZED POWDER
97878963 9787896 3 SS METHOTREXATE. METHOTREXATE 1 Unknown 0 4 MG UNSPECIFIED /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
97878963 9787896 1 Pustular psoriasis
97878963 9787896 2 Psoriatic arthropathy
97878963 9787896 3 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
97878963 9787896 Cell marker increased
97878963 9787896 Drug ineffective

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
97878963 9787896 1 201003 0
97878963 9787896 2 201003 0